Tuesday, September 26, 2017 2:32:08 AM
Oren1976, you can't just average the trial enrollment dates. Indeed, events happen *after* a given number of months pass.
As an example to prove my point, assume half the patients were enrolled in March 2016 and the other half in March 2017, the average enrollment date is September 2016. However, most of the March 2017 cohort would be expected to be alive in both arms...
Without having a precise idea of the enrollment dates, one cannot make predictions about the date when 189 events will be reached. Only those privy to the actual enrollment dates can do such predictions.
We know that the official date for the meeting regarding p3 top-line results with the FDA is scheduled for early 2018. The rest is hearsay.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM